Oklahoma Clinical Trials

Recruiting studies in Oklahoma

• Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)
  NCT06960798University of OklahomaProstate CancerOklahoma City, OK
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerOklahoma City, OK
• A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
  NCT07737743PHASE2Novartis PharmaceuticalsSjögren's DiseaseOklahoma City, OK
• Low Level Tragus Stimulation in Acute Decompensated Heart Failure
  NCT02898181NAUniversity of OklahomaAcute Decompensated Heart FailureOklahoma City, OK
• Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
  NCT07661056PHASE3Biohaven Therapeutics Ltd.Graves DiseaseNorman, OK
• Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
  NCT07817875PHASE3Eli Lilly and CompanyObesityOklahoma City, OK
• The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
  NCT07143019NAphenox Inc.Hemorrhagic StrokeOklahoma City, OK
• A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
  NCT06293053PHASE3SanofiPrurigo NodularisTulsa, OK
• Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
  NCT07437950PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaOklahoma City, OK
• Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  NCT07195734PHASE2National Cancer Institute (NCI)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Oklahoma City, OK
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801PHASE3Merck Sharp & Dohme LLCCrohn's DiseaseOklahoma City, OK
• A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
  NCT07525375PHASE2AstraZenecaAsthmaOklahoma City, OK

See all 704 recruiting trials →

Clinical trials by Oklahoma metro

• Oklahoma City

Popular conditions in Oklahoma

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Oklahoma?

Corterve aggregates actively recruiting clinical trials with sites in Oklahoma from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Oklahoma free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Oklahoma?

Oklahoma research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.